CLDX peer analysis
Celldex Therapeutics (CLDX) against its competitors: price, today's move, 1-year return and market value side by side.
CLDX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ADAG Adagene | $2.29 | -8.76% | 28.65% | – |
| AGEN Agenus | $6.53 | -4.53% | 64.48% | $308.91M |
| CGEN Compugen | $1.98 | 0.00% | 11.86% | $187.56M |
| CMPX Compass Therapeutics | $0.77 | -2.42% | -79.48% | – |
| IMNM Immunome | $19.57 | -0.10% | 21.78% | – |
| MGNX MacroGenics | $2.33 | -2.92% | 40.36% | $152.88M |
| NRIX Nurix Therapeutics | $25.70 | 0.00% | 98.61% | – |
| RCUS Arcus Biosciences | $17.85 | -1.87% | -9.48% | $2.32B |
| VRXA Veraxa Biotech | $1.03 | -9.65% | – | – |
| XNCR Xencor | $29.45 | -0.71% | 100.20% | $2.22B |
| CLDX Celldex Therapeutics | $29.04 | -3.52% | 8.64% | $2.36B |
- CLDX's peers: ADAG (Adagene), AGEN (Agenus), CGEN (Compugen), CMPX (Compass Therapeutics), IMNM (Immunome), MGNX (MacroGenics), NRIX (Nurix Therapeutics), RCUS (Arcus Biosciences).
Updated 2026-11-03 12:33 UTC